These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28690987)

  • 1. The influence of gonadotropin releasing hormone agonist treatment on the body weight and body mass index in girls with idiopathic precocious puberty and early puberty.
    Kim SW; Kim YB; Lee JE; Kim NR; Lee WK; Ku JK; Kim EJ; Jung SH; Chung WY
    Ann Pediatr Endocrinol Metab; 2017 Jun; 22(2):95-101. PubMed ID: 28690987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Near final adult height, and body mass index in overweight/obese and normal-weight children with idiopathic central precocious puberty and treated with gonadotropin-releasing hormone analogs.
    Sinthuprasith P; Dejkhamron P; Wejaphikul K; Unachak K
    J Pediatr Endocrinol Metab; 2019 Dec; 32(12):1369-1375. PubMed ID: 31605579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The different effects of gonadotropin-releasing hormone agonist therapy on body mass index and growth between normal-weight and overweight girls with central precocious puberty.
    Yang WJ; Ko KH; Lee KH; Hwang IT; Oh YJ
    Ann Pediatr Endocrinol Metab; 2017 Mar; 22(1):49-54. PubMed ID: 28443259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of GnRH agonist treatment on body mass index in girls with idiopathic central precocious puberty.
    Vuralli D; Ozon ZA; Gonc EN; Alikasifoglu A; Kandemir N
    J Pediatr Endocrinol Metab; 2020 Jan; 33(1):99-105. PubMed ID: 31804960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of gonadotropin-releasing hormone agonist therapy on body mass index and growth in girls with idiopathic central precocious puberty.
    Anık A; Çatlı G; Abacı A; Böber E
    Indian J Endocrinol Metab; 2015; 19(2):267-71. PubMed ID: 25729690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in body mass index in boys with central precocious puberty over 2 years of gonadotropin-releasing hormone agonist therapy.
    Lim KI; Lee HS; Hwang JS
    Ann Pediatr Endocrinol Metab; 2020 Sep; 25(3):169-173. PubMed ID: 33017886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in body mass index during gonadotropin-releasing hormone agonist treatment for central precocious puberty and early puberty.
    Lee HS; Yoon JS; Roh JK; Hwang JS
    Endocrine; 2016 Nov; 54(2):497-503. PubMed ID: 27444748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body mass index evolution and ovarian function in adolescent girls who received GnRH agonist treatment for central precocious puberty or early and fast puberty.
    Buyukyilmaz G; Koca SB; Adiguzel KT; Gurbuz F; Boyraz M
    J Pediatr Endocrinol Metab; 2023 Nov; 36(11):1044-1051. PubMed ID: 37735929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment outcomes of gonadotropin-releasing hormone agonist in obese girls with central precocious puberty.
    Kim HR; Nam HK; Rhie YJ; Lee KH
    Ann Pediatr Endocrinol Metab; 2017 Dec; 22(4):259-265. PubMed ID: 29301187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in body mass index in children on gonadotropin-releasing hormone agonist therapy with precocious puberty, early puberty or short stature.
    Censani M; Feuer A; Orton S; Askin G; Vogiatzi M
    J Pediatr Endocrinol Metab; 2019 Oct; 32(10):1065-1070. PubMed ID: 31465296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Body Mass Index in Girls with Idiopathic Central Precocious Puberty under Gonadotropin-Releasing Hormone Analogue Therapy: The Spanish Registry.
    Corripio R; Soriano-Guillén L; Herrero FJ; Cañete R; Castro-Feijoó L; Escribano A; Espino R; Labarta JI; Argente J
    Horm Res Paediatr; 2016; 86(3):154-160. PubMed ID: 27529349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of gonadotropin-releasing hormone agonists on anthropometric change in girls with central precocious puberty.
    Yoon JW; Park HA; Lee J; Kim JH
    Korean J Pediatr; 2017 Dec; 60(12):395-402. PubMed ID: 29302264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of baseline body mass index under gonadotropin-suppressive therapy in girls with idiopathic precocious puberty.
    Arrigo T; De Luca F; Antoniazzi F; Galluzzi F; Segni M; Rosano M; Messina MF; Lombardo F
    Eur J Endocrinol; 2004 Apr; 150(4):533-7. PubMed ID: 15080784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of GnRH analog treatment on BMI in children treated for precocious puberty: a systematic review and meta-analysis.
    Zhu X; Qin J; Xue W; Li S; Zhao M; Yingliang Jin
    J Pediatr Endocrinol Metab; 2024 Apr; 37(4):297-308. PubMed ID: 38407229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do GnRH Agonists Really Increase Body Weight Gain? Evaluation of a Multicentric Portuguese Cohort of Patients With Central Precocious Puberty.
    Leite AL; Galo E; Antunes A; Robalo B; Amaral D; Espada F; Castro S; Simões Dias S; Limbert C
    Front Pediatr; 2022; 10():816635. PubMed ID: 35311046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of gonadotropin-releasing hormone analogs on body mass index in girls with idiopathic central precocious puberty: a long-term follow-up study].
    Yuan JN; Liang L; Cai XD; Li Z; Bai M; Gu CP
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Nov; 13(11):896-9. PubMed ID: 22099200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotropin releasing hormone analogue therapy in girls with idiopathic precocious puberty/early-fast puberty: dynamics in adiposity indices, eating habits and quality of life.
    Loochi SA; Demol S; Nagelberg N; Lebenthal Y; Phillip M; Yackobovitch-Gavan M
    J Pediatr Endocrinol Metab; 2021 Mar; 34(3):373-383. PubMed ID: 33609438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing adult height gain and menarcheal age between girls with central precocious puberty treated with gonadotropin-releasing hormone agonist alone and those treated with combined growth hormone therapy.
    Kim MS; Koh HJ; Lee GY; Kang DH; Kim SY
    Ann Pediatr Endocrinol Metab; 2019 Jun; 24(2):116-123. PubMed ID: 31261476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Change in body mass index and insulin resistance after 1-year treatment with gonadotropin-releasing hormone agonists in girls with central precocious puberty.
    Park J; Kim JH
    Ann Pediatr Endocrinol Metab; 2017 Mar; 22(1):27-35. PubMed ID: 28443256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the resilience of the girls with central precocious puberty treated with gonadotropin-releasing hormone analog.
    Odabasi Gunes S; Akin O; Eray S
    J Pediatr Endocrinol Metab; 2021 Nov; 34(11):1379-1384. PubMed ID: 34313086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.